| Literature DB >> 30288425 |
Rami A Ahmed1,2,3,4,5, Michele L McCarroll1,2,3,4,5, Alan Schwartz1,2,3,4,5, M David Gothard1,2,3,4,5, S Scott Atkinson1,2,3,4,5, Patrick G Hughes1,2,3,4,5, Jose Ramon Cepeda Brito1,2,3,4,5, Lori Assad1,2,3,4,5, Jerry G Myers1,2,3,4,5, Richard L George1,2,3,4,5.
Abstract
Background: Medical decision making is a critical, yet understudied, aspect of medical education. Aims: To develop the Medical Judgment Metric (MJM), a numerical rubric to quantify good decisions in practice in simulated environments; and to obtain initial preliminary evidence of reliability and validity of the tool.Entities:
Keywords: clinical judgment; decision making; medical judgment; simulation
Year: 2017 PMID: 30288425 PMCID: PMC6125013 DOI: 10.1177/2381468317715262
Source DB: PubMed Journal: MDM Policy Pract ISSN: 2381-4683
Figure 1Medical Judgment Metric: (a) History and Physical domain; (b) Diagnostic domain; (c) Interpretation domain; (d) Management domain. The Medical Judgment Metric (MJM) is a tool that can be applied to anyone interested in assessing medical decision-making capacity. The raters of the MJM should be well experienced physicians.
Content Validity Index Average Percentage of Agreement on Medical Judgment Metric Items in the Clinical Domains Needing Team Agreement
| History and Physical | Diagnostic Evaluation | Interpretation of Diagnostic | Management | Other category | |
|---|---|---|---|---|---|
| 1. Lacks foundational knowledge to apply to diagnostic testing and procedures to patient care. | — | 85% | 5% | 10% | — |
| 2. Understands basic necessity for acquisition of diagnostic studies. | 5% | 85% | 10% | — | — |
| 3. Recognizes disease presentations that deviate from common patterns and require complex decision making as a result of the interpretation of diagnostic testing. | — | — | 87.5% | 12.5% | — |
| 4. Orders and correctly prioritizes appropriate diagnostic testing. | 7.5% | 85% | 2.5% | 5% | — |
| 5. Orders and correctly prioritizes appropriate diagnostic testing taking into account subtle and/or conflicting history and physical findings. | 5% | 81.25% | 8.75% | 5% | — |
| 6. Inability to recognize patients’ central clinical problem or develops very limited differential diagnosis. | 6.25% | — | 6.25% | 62.5% | 25% |
| 7. Inconsistently recognizes patient’s central clinical problem or develops limited differential diagnosis. | 6.25% | — | 6.25% | 62.5% | 25% |
| 8. Uses all available medical information to develop an appropriate differential diagnosis. | 6.25% | — | 6.25% | 62.5% | 25% |
| 9. Synthesizes all of the available data and narrows and prioritizes the list of weighted differential diagnoses to determine appropriate management including those that are the greatest potential for morbidity or mortality. | 8.75% | 2.5% | 8.75% | 80% | — |
| 10. Does not understand the concept of pretest probability and test performance characteristics. | — | 48.75% | 15% | 11.25% | — |
| 11. Understands the concept of pretest probability and test performance characteristics and uses the diagnostic testing based on the pretest probability of disease and the likelihood of test results altering management. | — | 48.75% | 15% | 11.25% | — |
| 12. Fails to recognize patient’s central clinical problem. | 25% | — | — | 50% | 25% |
| 13. Does not seek or is overly reliant on secondary data. | 25% | — | — | 50% | 25% |
| 14. Synthesizes data to generate a prioritized differential diagnosis and problem list. | 10% | 2.5% | 5% | 37.5% | 25% |
| 15. Ability to utilize diagnostic testing in alternative and/or off-label use in crisis situations or unusual circumstances. | — | 59.75% | 13.75% | 27.5% | — |
| 16. Inability to recognize disease presentations that deviate from common patterns. | — | — | 6.25% | 43.7% | 50% |
| 17. Consistently recognizes disease presentations that deviate from common patterns. | — | — | 6.25% | 43.7% | 50% |
| 18. Inability to recognize disease presentations that deviate from common patterns. | — | — | 6.25% | 43.7% | 50% |
| 19. Fails to recognize potentially life-threatening problems. | 31.25% | 6.25% | 6.25% | 56.25% | — |
| 20. Inconsistently recognizes patient’s central clinical problem or develops limited differential diagnosis. | 31.25% | 6.25% | 6.25% | 31.25% | 25% |
| 21. Unable to recognize critical/severely abnormal findings warranting immediate intervention. | 35% | — | 35% | 30% | — |
| 22. Inconsistently able to recognize critical/severely abnormal findings warranting immediate intervention. | 35% | — | 35% | 30% | — |
| 23. Consistently able to recognize critical/severely abnormal findings warranting immediate intervention. | 35% | — | 35% | 30% | — |
Reliability of Summed Rater Evaluations by Scenario
| Scenario | ICC Value (95% CI) | |
|---|---|---|
| Biliary colic | 0.986 (0.976-0.992) | <0.001 |
| Pneumothorax | 0.980 (0.965-0.989) | <0.001 |
| STEMI | 0.965 (0.941-0.980) | <0.001 |
| Renal colic | 0.987 (0.978-0.993) | <0.001 |
Note: ICC = intraclass correlation coefficient; CI = confidence interval; STEMI = ST elevation myocardial infarction. ICC values are two-way mixed average values. P value from F test of ICC value equal to 0.
Reliability of Rater Evaluations by Scenario Outcome
| Scenario | Fleiss’ Kappa Value (95% CI) | |
|---|---|---|
| Biliary colic | 0.804 (0.670-0.938) | <0.001 |
| Pneumothorax | 0.874 (0.727-1.000) | <0.001 |
| STEMI | 0.906 (0.751-1.000) | <0.001 |
| Renal colic | 0.791 (0.656-0.926) | <0.001 |
Note: CI = confidence interval; STEMI = ST elevation myocardial infarction. P value from test of Fleiss Kappa value equal to 0.
Concurrent Validation of Categorized Rater Scores to Simulation Outcomes
| Simulation Outcome | |||||
|---|---|---|---|---|---|
| Scenario/Outcome Average Score Cutoff | Loss of Life | Loss of Function | Stabilization | Cohen’s Kappa | Volume Under Surface |
| Biliary colic | 0.880 | 0.86 | |||
| Loss of Life: Score <22.33 | 13 | ||||
| Loss of Function: 22.33 ≤ Score ≤ 27.83 | 6 | 3 | |||
| Stabilization: Score > 27.83 | 18 | ||||
| Pneumothorax | 0.855 | 0.25 | |||
| Loss of Life: Score < 24.83 | 12 | 3 | |||
| Loss of Function: 24.83 ≤ Score ≤ 26.00 | 1 | ||||
| Stabilization: Score > 26.00 | 23 | ||||
| STEMI | 0.868 | 0.6 | |||
| Loss of Life: Score < 24.5 | 19 | 1 | |||
| Loss of Function: 24.50 ≤ Score ≤ 28.16 | 2 | 2 | |||
| Stabilization: Score > 28.16 | 16 | ||||
| Renal colic | 0.851 | 0.25 | |||
| Loss of Life: Score < 19.67 | 12 | ||||
| Loss of Function: 19.67 ≤ Score ≤ 23.00 | 1 | ||||
| Stabilization: Score > 23.00 | 3 | 24 | |||
Note: STEMI = ST elevation myocardial infarction. Average score cutoff is determined by providing priority to loss of life followed by stabilization. The volume under the surface (VUS) is calculated at the fixed cutoff scores with chance performance equal to a VUS value of 0.17 and perfection equal to a VUS value of 1.00.